These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 20070724

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS, Qvigstad E, Nesheim BI.
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [Abstract] [Full Text] [Related]

  • 24. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.
    Panay N, Pritsch M, Alt J.
    Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596
    [Abstract] [Full Text] [Related]

  • 25. Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone.
    Czajkowski K, Sienko J, Mogilinski M, Bros M, Szczecina R, Czajkowska A.
    Fertil Steril; 2007 Mar; 87(3):613-8. PubMed ID: 17126337
    [Abstract] [Full Text] [Related]

  • 26. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
    Barbosa MW, Silva LR, Navarro PA, Ferriani RA, Nastri CO, Martins WP.
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS.
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [Abstract] [Full Text] [Related]

  • 29. Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study.
    Ferrero S, Gerbaldo D, Fulcheri E, Cristoforoni P.
    Minerva Ginecol; 2002 Dec; 54(6):519-30. PubMed ID: 12432337
    [Abstract] [Full Text] [Related]

  • 30. The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study.
    Inal MM, Ertopçu K, Arici A, Ozelmas I.
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):197-202. PubMed ID: 15006266
    [Abstract] [Full Text] [Related]

  • 31. Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.
    Quereux C, Pornel B, Bergeron C, Ferenczy A.
    Maturitas; 2006 Feb 20; 53(3):299-305. PubMed ID: 16043317
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study.
    Cicinelli E, Pinto V, Tinelli R, Saliani N, De Leo V, Cianci A.
    Fertil Steril; 2007 Sep 20; 88(3):698-701. PubMed ID: 17678902
    [Abstract] [Full Text] [Related]

  • 34. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
    Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J.
    Menopause Int; 2009 Jun 20; 15(2):63-9. PubMed ID: 19465671
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2001 Jun 20; 6(2):93-101. PubMed ID: 11518454
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL.
    Menopause; 2009 Jun 20; 16(5):978-83. PubMed ID: 19390463
    [Abstract] [Full Text] [Related]

  • 39. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug 20; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.